Cellectar Biosciences, Inc. (CLRB)
3.20
+0.16
(+5.26%)
USD |
NASDAQ |
Feb 09, 12:43
Cellectar Biosciences Market Cap : 5.798M for Feb. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Imunon, Inc. | 7.108M |
| PDS Biotechnology Corp. | 39.54M |
| PAVmed, Inc. | 10.13M |
| ACADIA Pharmaceuticals, Inc. | 3.900B |
| Alnylam Pharmaceuticals, Inc. | 42.62B |
Market Cap Related Metrics
| PEG Ratio | -0.002 |
| Price to Book Value | 0.7756 |
| Price | 3.20 |
| Earnings Yield | -202.1% |
| PEGY Ratio | -0.002 |